SHREWSBURY – Town Manager Kevin Mizikar informed the Select Board on Sept. 24 that Repligen, a “bioprocessing-focused life sciences company,” will lease out the vast majority of the large Centech Park North building along South Street and Route 20.
The company is currently fitting out the space and signage has been installed, said Mizikar.
Repligen was founded in 1981 and “inspire[s] advances in bioprocessing through the development and commercialization of high-value products and flexible solutions that address critical steps in the production of biologic drugs,” according to its website.
The company is headquartered in Waltham and has dozens of offices throughout the world, including locations in Auburn, Hopkinton and Marlborough.
Repligen coming to Centech Park North represents a major step in the town’s decades-long effort to find productive uses for the 60-acre Allen Farm (or Allen Property).
RELATED CONTENT: Shrewsbury Planning Board approves Centech development
In 2002, the Shrewsbury Development Corporation was formed to facilitate the redevelopment of the property. After years of business-friendly practices designed to attract commercial development, the property was sold in 2021 to NorthBridge Partners, LLC for $6.5 million.
Centech Park North was subsequently developed.
“It’s a really great outcome, and a tribute to town staff and NorthBridge Partners, who developed the [building], to get a very high-end, lower-impact use within that space. That’s something that we always focus on, creating jobs for the community. We look forward to working with Repligen in the future once they begin operations here in Shrewsbury,” said Mizikar.
